Heart Failure with Preserved Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Preserved Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease [Phase 4]
A Phase 4 trial evaluating empagliflozin for heart failure with preserved ejection fraction in patients with end-stage renal disease on dial…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF [NA]
A Massachusetts General Hospital study is recruiting to assess how common transthyretin amyloidosis is and how to predict its presence in am…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction
A clinical trial evaluating manganese-enhanced MRI imaging for heart failure with preserved ejection fraction in patients with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Peripheral Microvascular Blood Flow in ANOCA
A completed clinical trial evaluating peripheral microvascular blood flow in Angina with nonobstructive coronary arteries and heart failure …
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Clinical Characteristics and Predictors of Adverse Outcomes in HFpEF
This clinical trial update reports on the characteristics and predictors of adverse outcomes in heart failure with preserved ejection fracti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Acute Effects of Exogenous Ketone Ester Administration in Heart Failure [Phase 2]
Phase 2 trial evaluating the acute effects of an exogenous ketone ester in heart failure with preserved ejection fraction; results have been…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: NMES in HF Patients to Improve Functional Recovery Following Hospitalization [NA]
A completed clinical trial evaluating neuromuscular electrical stimulation (NMES) to aid functional recovery in patients with heart failure …
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial [Phase 4]
A Phase 4 randomized trial of polydiuretic therapy for heart failure with preserved ejection fraction has been terminated.
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department [Phase 3]
Phase 3 clinical trial evaluating empagliflozin for heart failure with preserved ejection fraction in a cardiology outpatient setting; curre…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES [Phase 1, Phase 2]
Clinical trial update indicates that Avmacol ES is being studied in Phase 1/2 to prevent age-associated cardiac and vascular dysfunction, wi…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Heart Failure Therapy and Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Novartis reports completion of a clinical trial evaluating heart failure therapy and patient outcomes in individuals with mildly reduced or …
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Effects of an Exercise Program in Women Over 60 yr. With HFpEF and Sarcopenia on Functional Capacity and Quality of Life [NA]
A not-yet-recruiting clinical trial is investigating whether an exercise program improves functional capacity and quality of life in women o…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction [Phase 3]
A Phase 3 randomized interventional trial evaluating initiation of spironolactone in heart failure with preserved ejection fraction is curre…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction [NA]
A clinical trial is investigating rifaximin for potential effects on cardiac function in patients with heart failure with preserved ejection…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: The Gut Microbiota and Metabolites in HFpEF
This clinical trial update describes a study investigating the gut microbiota and related metabolites in heart failure with preserved ejecti…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Pogejiuxin Decoction Combination of Conventional Western Medicine for the Treatment of Heart Failure With Preserved Ejection Fraction [NA]
A completed clinical trial evaluating Pogejiuxin Decoction in combination with conventional Western medicine for heart failure with preserve…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: MyoMobile Study: App-based Activity Coaching in Patients with Heart Failure and Preserved Ejection Fraction
The MyoMobile Study, an app-based activity coaching trial in patients with heart failure with preserved ejection fraction, has completed.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Remote Ischaemic Conditioning (RIC) in Heart Failure [NA]
This entry provides a clinical trial update on Remote Ischaemic Conditioning for heart failure, sponsored by the University of Leicester, in…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of pulmonary artery denervation for pulmonary hypertension associated with left he…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction [Phase 4]
Phase 4 trial update evaluating empagliflozin for improving functional capacity in heart failure with preserved ejection fraction has comple…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation [Phase 4]
Phase 4 clinical trial update evaluating colchicine for patients with heart failure with preserved ejection fraction and inflammation; the t…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients [NA]
A clinical trial investigates whether intradialytic exercise improves left ventricular diastolic function in patients undergoing hemodialysi…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXercise
Clinical trial update for the Weight Loss Surgery and Comprehensive Cardiometabolic Responses to Exercise study from Massachusetts General H…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Sleep Apnea in Heart Failure With Preserved Ejection Fraction
This completed clinical trial examined sleep apnea in patients with heart failure with preserved ejection fraction.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF [Phase 2]
Phase 2A double-blind, placebo-controlled dose-escalation study evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of H…